Dimetapp hasn’t been taken off the marketplace. It’s simply that the FDA warned that inexact dosing may result in an overdose in kids; GSK has now not reported any antagonistic results thus far.
The recalled numerous Robitussin and Dimetapp have been disbursed national between Feb. 5 and June 3 and elevate the GSK and Pfizer logo names on their labels.